Somaxon Pharmaceuticals Articles

Pernix Thera rescues struggling Somaxon with stock deal worth $25 million

12 December 2012

Mylan settles litigation with Somaxon relating to its generic Silenor

19 July 2012

Paladin buys ex-US rights to Somaxon’s insomnia drug Silenor for up to $129 million

13 June 2011

Somaxon shares rocket nearly 34%% on news of Silenor deal with P&G

27 August 2010

Showing 1-4 of 4 articles

Go to beginningPrevious
  • 1
NextGo to end